# Efficacy and Safety Study of Dysport® Used for Migraine Prophylaxis

> **NCT00301665** · PHASE2 · COMPLETED · sponsor: **Ipsen** · enrollment: 138 (actual)

## Conditions studied

- Migraine

## Interventions

- **BIOLOGICAL:** Botulinum toxin type A

## Key facts

- **NCT ID:** NCT00301665
- **Lead sponsor:** Ipsen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-02
- **Primary completion:** —
- **Final completion:** 2005-03
- **Target enrollment:** 138 (ACTUAL)
- **Last updated:** 2020-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00301665

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00301665, "Efficacy and Safety Study of Dysport® Used for Migraine Prophylaxis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00301665. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*